{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T05:18:47Z","timestamp":1787635127026,"version":"build-2736575974"},"reference-count":23,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>This study aimed to quantify throat symptom burden using the Reflux Symptom Index (RSI) in laryngopharyngeal reflux (LPR)-screened-negative patients before and during SARS-CoV-2 infection in the Omicron-dominant period, and to identify factors independently associated with RSI score increase during infection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      This prospective follow-up study enrolled 428 LPR-screened-negative participants with SARS-CoV-2 infection during the Omicron-dominant period (December 2022\u2013March 2023) in China. RSI questionnaires were administered at two time points: pre-infection baseline and follow-up. The second questionnaire was completed \u22654\u202fweeks after infection onset, and participants retrospectively recalled acute symptoms experienced during the first 2\u202fweeks of illness. Paired-samples\n                      <jats:italic>t<\/jats:italic>\n                      -tests, McNemar\u2019s test, and multivariable linear regression were used for analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Mean age was 37.59\u202f\u00b1\u202f11.56\u202fyears; 64.7% were female. Mean total RSI score increased significantly from 5.04\u202f\u00b1\u202f5.98 at baseline to 9.68\u202f\u00b1\u202f7.48 during infection (mean \u0394RSI\u202f=\u202f+4.64;\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). The proportion with RSI\u202f&amp;gt;\u202f13 rose from 9.1 to 25.9% (\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001). The most common symptoms during infection were troublesome cough (79.2%), throat clearing (76.9%), and excess throat mucus (72.4%). Multivariable linear regression identified three factors independently associated with greater RSI increase: stuffy\/runny nose (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f3.30, 95% CI 1.99\u20134.60,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f&amp;lt;\u202f0.001), fatigue (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f2.53, 95% CI 0.83\u20134.23,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.004), and muscle pains (\n                      <jats:italic>\u03b2<\/jats:italic>\n                      \u202f=\u202f1.96, 95% CI 0.59\u20133.32,\n                      <jats:italic>p<\/jats:italic>\n                      \u202f=\u202f0.005).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>SARS-CoV-2 infection during the Omicron-dominant period significantly worsened throat symptoms in LPR-screened-negative patients. Patients presenting with concurrent fatigue, nasal congestion, and muscle pain showed higher RSI increases and may warrant closer clinical attention.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fmed.2026.1923973","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:37Z","timestamp":1787631817000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Using the reflux symptom index to quantify throat symptom burden in LPR-screened-negative patients before and during SARS-CoV-2 infection in China: a prospective follow-up study"],"prefix":"10.3389","volume":"13","author":[{"given":"Ying","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingjia","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology Head and Neck Surgery, Changde Hospital, Xiangya School of Medicine, Central South University (The First People\u2019s Hospital of Changde City)","place":["Changde, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"ref1","year":"2022"},{"key":"ref2","year":"2022"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1016\/S0140-6736(22)00327-0","article-title":"Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID study","volume":"399","author":"Menni","year":"2022","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/j.virs.2022.07.014","article-title":"Clinical characteristics of 310 SARS-CoV-2 omicron variant patients and comparison with Delta and Beta variant patients in China","volume":"37","author":"Yang","year":"2022","journal-title":"Virol Sin"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1016\/j.jvoice.2023.04.003","article-title":"Increased incidence of ulcerative laryngitis during spring 2022 omicron-variant wave of COVID19","volume":"39","author":"Abdel-Aty","year":"2022","journal-title":"J Voice"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S0892-1997(02)00097-8","article-title":"Validity and reliability of the reflux symptom index (RSI)","volume":"16","author":"Belafsky","year":"2002","journal-title":"J Voice"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jvoice.2013.12.006","article-title":"Linguistic adaptation, reliability, validation, and responsivity of the Chinese version of reflux symptom index","volume":"30","author":"Li","year":"2016","journal-title":"J Voice"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1097\/00005537-200108000-00001","article-title":"The validity and reliability of the reflux finding score (RFS)","volume":"111","author":"Belafsky","year":"2001","journal-title":"Laryngoscope"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.3390\/v14112543","article-title":"Omicron variant generates a higher and more sustained viral load in nasopharynx and saliva than the Delta variant of SARS-CoV-2","volume":"14","author":"Granerud","year":"2022","journal-title":"Viruses"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e29268","DOI":"10.1002\/jmv.29268","article-title":"Omicron induced distinct immune respiratory transcriptomics signatures compared to pre-existing variants in critically ill COVID-19 patients","volume":"95","author":"Bay","year":"2023","journal-title":"J Med Virol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1021\/acschemneuro.0c00122","article-title":"Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms","volume":"11","author":"Baig","year":"2020","journal-title":"ACS Chem Neurosci"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.26355\/eurrev_202101_24679","article-title":"Pathogenesis of dysgeusia in COVID-19 patients: a scoping review","volume":"25","author":"Mahmoud","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"781968","DOI":"10.3389\/fcimb.2021.781968","article-title":"Severe COVID-19 is associated with an altered upper respiratory tract microbiome","volume":"11","author":"Shilts","year":"2022","journal-title":"Front Cell Infect Microbiol"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1080\/08830185.2021.1965316","article-title":"COVID-19 and oral diseases: assessing manifestations of a new pathogen in oral infections","volume":"41","author":"Naqvi","year":"2022","journal-title":"Int Rev Immunol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1146\/annurev-virology-091919-064959","article-title":"Sex differences in respiratory viral pathogenesis and treatments","volume":"8","author":"Ursin","year":"2021","journal-title":"Annu Rev Virol"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1177\/0194599813483443","article-title":"Evaluating the autonomic nervous system in patients with laryngopharyngeal reflux","volume":"148","author":"Huang","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"ref17","year":"2022"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2101147","DOI":"10.2807\/1560-7917.ES.2021.26.50.2101147","article-title":"Outbreak caused by the SARS-CoV-2 omicron variant in Norway, November to December 2021","volume":"26","author":"Brandal","year":"2021","journal-title":"Euro Surveill"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"583373","DOI":"10.3389\/fimmu.2020.583373","article-title":"The inflammasome in times of COVID-19","volume":"11","author":"de Rivero Vaccari","year":"2020","journal-title":"Front Immunol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"2124","DOI":"10.1002\/jmv.26036","article-title":"The impact of laryngopharyngeal reflux disease on 95 hospitalized patients with COVID-19 in Wuhan, China: a retrospective study","volume":"92","author":"Jiang","year":"2020","journal-title":"J Med Virol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1002\/jmv.27562","article-title":"Omicron (B.1.1.529 variant of SARS-CoV-2); an emerging threat: current global scenario","volume":"94","author":"Mohapatra","year":"2022","journal-title":"J Med Virol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"3516","DOI":"10.1016\/j.vaccine.2022.04.068","article-title":"Assessing vaccine effectiveness against severe COVID-19 disease caused by Omicron variant. Report from a meeting of the World Health Organization","volume":"40","author":"Feikin","year":"2022","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1002\/jmv.26136","article-title":"The association between laryngopharyngeal reflux and COVID-19 is still not demonstrated","volume":"92","author":"Lechien","year":"2020","journal-title":"J Med Virol"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1923973\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:23:38Z","timestamp":1787631818000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2026.1923973\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":23,"alternative-id":["10.3389\/fmed.2026.1923973"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2026.1923973","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"article-number":"1923973"}}